Owner Noven Pharmaceuticals, Inc.

Inventors Houze, David; Nguyen, Viet

Agent Davies Collison Cave

Pub. Number AU-B-2002320038

PCT Number PCT/US02/16579

PCT Pub. Number WO2002/102390

Priority 60/298,381 18.06.01 US; 09/948,107 07.09.01 US

Filing date 18 June 2002

Wipo publication date 2 January 2003

Acceptance publication date 5 July 2007

A61K 31/56 (2006.01) - Compounds containing cyclopenta[a]hydrophenanthrene ring systems

A61K 9/70 (2006.01) Medicinal preparations characterised by special physical form - Web, sheet or filament bases

A61K 31/403 (2006.01) - condensed with carbocyclic rings, e.g. carbazole

A61K 31/565 (2006.01) - not substituted in position 17 beta by a carbon atom, e.g. oestrane, oestradiol

A61K 31/567 (2006.01) - substituted in position 17 alpha, e.g. mestranol, norethandrolone

A61K 31/5685 (2006.01)

A61K 38/55 (2006.01) Medicinal preparations containing peptides - Protease inhibitors

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 47/10 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Alcohols

A61K 47/12 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Carboxylic acids

A61K 47/32 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds

A61K 47/34 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61P 5/26 (2006.01) Drugs for disorders of the endocrine system

A61P 5/30 (2006.01) Drugs for disorders of the endocrine system

A61P 9/12 (2006.01) Drugs for disorders of the cardiovascular system

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups